Nucor Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Nucor Corporation trades at $230.8 (market cap $52.55B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: Nucor Corporation pays a 0.97% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Nucor Corporation nearer its low. Which is the better fit depends on your goals.
| NUE | XBI | |
|---|---|---|
Market Cap | $52.55B | — |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $266.35 | $164.28 |
52-Week Low | $131.78 | $85.16 |
Enterprise Value | $57.19B | — |
Dividend Yield | 0.97% | — |
Signals from Pluang's Aura AI — not financial advice
Nucor (NUE) trades at $233.2, down 1.44% over 24 hours, with technical indicators showing a bearish trend near key support at $228. The company reported mixed recent earnings, beating in Q1 2026 but missing in Q4 2025, with Q2 2026 results expected soon. Revenue has stabilized around $32.5B in 2025 after declines from 2022 peaks, while net margins compressed to 5.36%. Analyst sentiment remains positive with a 62.5% buy rating and $263.11 consensus target, supported by strong cash flow and a 53-year dividend growth streak.
NUE offers value with reasonable valuation multiples (P/E 22.89, P/S 1.55) and robust shareholder returns, but faces risks from steel demand volatility and margin pressure. The upcoming Q2 earnings report on July 27, 2026, will be critical for confirming growth trajectory amid economic uncertainties.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →